Save your place

Sign in to WhoBought

Please try again later.

Invesco's Alnylam Pharmaceuticals, Inc. (ALNY) position

Yes: as of Q1 2026, Invesco holds 1.3M shares of ALNY worth $427M (0.1% of the disclosed portfolio). Held since at least Q1 2021; that opening coverage snapshot is not counted as a purchase.
View full portfolio →
Current value
$427M
Shares held
1.3M
% of portfolio
0.1%
Est. average buy price (i)
$315.16
est. since Q2 2024
Quarter-end price
$330.87

Estimated trade prices

Average price in quarters with purchases
$326.76
Average prices in quarters with sales
  • Q1 2026: $340.17 (874K shares sold)
  • Q4 2024: $262.99 (137K shares sold)
  • Q4 2023: $170.34 (40K shares sold)
  • Q3 2023: $191.12 (174K shares sold)
  • Q1 2023: $210.20 (302K shares sold)
  • Q4 2022: $213.29 (68K shares sold)
  • Q2 2022: $141.87 (800K shares sold)
  • Q4 2021: $185.86 (164K shares sold)
  • Q2 2021: $146.46 (214K shares sold)

ALNY price vs Invesco's position

Dates
$200$400$6002026Added 140K shares (10.4%) · Q3 2025. Average closing price $407.23 · Price range $311.12–$482.13140KsharespurchasedAdded 684K shares (46.2%) · Q4 2025. Average closing price $442.56 · Price range $391.17–$491.22684KsharespurchasedSold 874K shares (40.4%) · Q1 2026. Average closing price $340.17 · Price range $306.66–$422.50874Ksharessold← Earlier —7 purchases, 8 sells
Average closing price · filing quarter
$340.17
Price range · filing quarter
$306.66 – $422.50

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Reduced −874K −$297M −40.4% 1.3M May 12, 2026
Q4 2025 Added +684K +$303M +46.2% 2.2M Feb 19, 2026
Q3 2025 Added +140K +$57M +10.4% 1.5M Nov 13, 2025
Q2 2025 Added +428K +$118M +46.8% 1.3M Aug 13, 2025
Q1 2025 Added +355K +$91M +63.6% 914K May 12, 2025
Q4 2024 Reduced −137K −$36M −19.7% 558K Feb 13, 2025
Q3 2024 Added +303K +$79M +77.1% 696K Nov 12, 2024
Q2 2024 First covered 393K Aug 13, 2024
Q1 2024 Added +1K +$242K +0.8% 178K May 14, 2024
Q4 2023 Reduced −40K −$6.8M −18.3% 177K Feb 13, 2024
Q3 2023 Reduced −174K −$33M −44.5% 217K Nov 13, 2023
Q2 2023 Added +23K +$4.5M +6.2% 390K Aug 11, 2023
Q1 2023 Reduced −302K −$64M −45.2% 367K May 12, 2023
Q4 2022 Reduced −68K −$14M −9.2% 670K Feb 13, 2023
Q3 2022 First covered 738K Nov 14, 2022
Q2 2022 Reduced −800K −$113M −82.6% 169K Aug 15, 2022
Q1 2022 Added +79K +$12M +8.8% 969K May 16, 2022
Q4 2021 Reduced −164K −$30M −15.6% 890K Feb 14, 2022
Q3 2021 Added +52K +$9.8M +5.2% 1.1M Nov 15, 2021
Q2 2021 Reduced −214K −$31M −17.6% 1.0M Aug 17, 2021
Q1 2021 First covered 1.2M May 17, 2021
Data through Q1 2026 · filed May 12, 2026
21 grouped rows from 21 quarters

More Invesco positions

Common questions

Does Invesco own ALNY?

Yes. As of Q1 2026, Invesco disclosed 1.3M shares of ALNY, worth $427M. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Invesco buy ALNY?

Invesco held ALNY since at least Q1 2021, when this filing coverage begins; the opening snapshot is not a disclosed purchase. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Invesco sell ALNY?

The quarter-by-quarter table above shows each sale and reduction Invesco disclosed in ALNY. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of ALNY does Invesco own?

Invesco disclosed 1.3M shares of ALNY as of Q1 2026. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Invesco pay for ALNY?

Invesco began building the ALNY position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.